Royal Bank of Canada’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-74,700
Closed -$7.42M 7436
2019
Q3
$7.42M Sell
74,700
-2,800
-4% -$266K ﹤0.01% 1789
2019
Q2
$7.16M Sell
77,500
-342,800
-82% -$32.6M ﹤0.01% 1808
2019
Q1
$39.7M Buy
420,300
+190,700
+83% +$16.7M 0.02% 664
2018
Q4
$14.7M Sell
229,600
-385,900
-63% -$28.5M 0.01% 1187
2018
Q3
$55.1M Buy
615,500
+108,400
+21% +$9.58M 0.02% 554
2018
Q2
$40.3M Buy
507,100
+192,000
+61% +$15.9M 0.02% 661
2018
Q1
$28.1M Buy
315,100
+225,800
+253% +$21.7M 0.01% 876
2017
Q4
$9.32M Buy
89,300
+100
+0.1% +$11.3K ﹤0.01% 1661
2017
Q3
$13M Hold
89,200
0.01% 1362
2017
Q2
$11.6M Sell
89,200
-20,000
-18% -$2.45M 0.01% 1419
2017
Q1
$13.6M Sell
109,200
-71,300
-40% -$8.53M 0.01% 1293
2016
Q4
$20.9M Sell
180,500
-25,400
-12% -$2.83M 0.01% 1037
2016
Q3
$21.5M Sell
205,900
-388,300
-65% -$42M 0.01% 969
2016
Q2
$58.6M Buy
594,200
+502,300
+547% +$52M 0.03% 408
2016
Q1
$9.2M Sell
91,900
-130,200
-59% -$13.4M 0.01% 1431
2015
Q4
$26.6M Sell
222,100
-134,500
-38% -$15.6M 0.02% 771
2015
Q3
$38.6M Buy
356,600
+57,900
+19% +$7.19M 0.03% 452
2015
Q2
$34.6M Buy
298,700
+33,700
+13% +$3.85M 0.02% 540
2015
Q1
$30.5M Buy
265,000
+245,400
+1,252% +$29.3M 0.02% 600
2014
Q4
$2.19M Buy
19,600
+9,600
+96% +$1.01M ﹤0.01% 2262
2014
Q3
$948K Buy
+10,000
New +$902K ﹤0.01% 2890
2014
Q1
Sell
-394,800
Closed -$33.4M 6493
2013
Q4
$33.4M Sell
394,800
-56,400
-13% -$4.46M 0.02% 522
2013
Q3
$34.8M Buy
451,200
+41,400
+10% +$2.9M 0.03% 467
2013
Q2
$24M Buy
+409,800
New +$24.7M 0.02% 581

Other funds holding CELG

Royal Bank of Canada's CELG Position: Q4 2019 in Review

Royal Bank of Canada sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 915,127 shares — an estimated $90.9M sold.

Royal Bank of Canada first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $396M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Royal Bank of Canada reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Royal Bank of Canada sold 915,127 Celgene Corp shares in Q4 2019, an estimated $90.9M.
  • Royal Bank of Canada first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Royal Bank of Canada's Celgene Corp position peaked at $396M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Royal Bank of Canada's 13F filing for Q4 2019, filed 14 Feb 2020.